Cancer medicines
Lenvatinib
Lenvatinib
An oral targeted medicine inhibiting multiple growth and blood-vessel signals.
Sources checked · Introductory guide
On this page
How it works
It inhibits kinases including VEGFR to disrupt tumor growth and blood-vessel formation.[3]
Where it is used
Used in selected thyroid, liver, kidney and endometrial cancers. Eligibility and use alone or in combinations differ by cancer.[1]
Key safety points
Monitor blood pressure, urine protein, liver and kidneys. Disclose surgery or dental plans; severe bleeding, chest pain or dehydration needs urgent advice.[2]
Questions for your care team
- How should home blood pressure, urine or blood tests and procedure planning be managed?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Lenvatinib Mesylate (opens in a new tab)
- MedlinePlus · Lenvatinib Mesylate (opens in a new tab)
- NCI Drug Dictionary · Lenvatinib Mesylate (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.